Milan, 5 june 2023
Headquartered in Lodi and with 29 branches worldwide, the small multinational PHSE, active in pharmaceutical logistics, closed the 2022 financial year with a turnover of EUR 75 million, up 67% on the previous year. PHSE specialises in making life-saving drugs, biotechnology products and advanced therapies accessible to all players in the supply chain, from industry to pharmacist, doctor and patient. “This is an activity where compliance with temperatures, on-time delivery, traceability and monitoring of the product’s route are essential factors,” emphasises Executive President Eddy De Vita. A new hub in Bologna (Italy) will be opened by the summer and a new platform in Campania (Italy) is planned for the end of 2023.
Source: Il Sole 24 Ore, by Marco Sabella
